Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Patients with Active Psoriatic Arthritis: A Multicentre Randomized Placebo-Controlled Double-Blind Study
2006-000844-17Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in psoriatic arthritis (PsA) comparing Rituximab (MabThera) with Placebo (2 arms). Primary endpoint: PsARC response. Started May 2006; status: completed.
02
Drugs
rituximab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2006-000844-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000844-17.